Literature DB >> 14571477

Renal angioplasty and stenting under protection: the way for the future?

Michel Henry1, Isabelle Henry, Christos Klonaris, Antonio Polydorou, Pathrap Rath, Gopalakrishnan Lakshmi, Sriram Rajacopal, Michèle Hugel.   

Abstract

The purpose of this study was to evaluate the feasibility and safety of renal artery angioplasty and stenting utilizing a distal protection device to reduce the risk of intraprocedural artery embolism and avoid deterioration of the renal function. Fifty-six hypertensive patients (32 men; mean age, 66 +/- 11.8 years; range, 22-87) with atherosclerotic renal artery stenosis (8 bilateral) underwent angioplasty and stenting with distal protection in 65 renal arteries (58 ostial lesions). Five patients had a solitary kidney, 18 a renal insufficiency. The lesion was crossed either with a GuardWire temporary occlusion balloon (n = 38), which was inflated to provide parenchyma protection or with a filter (EPI Filter; n = 26), or with Angioguard (n = 1), which allows a continuous flow. Generated debris was aspirated and analyzed. Blood pressure and serum creatinine levels were followed. Immediate technical success was 100%. All lesions except one were stented, either directly (43 ostial lesions) or after predilatation (22 ostial lesions). Visible debris were aspirated with the PercuSurge in all patients or removed with filters in 80% of the patients. Mean particle number and diameter were 98.1 +/- 60.0 per procedure (range, 13-208) and 201.0 +/- 76.0 microm (range, 38-6,206), respectively. Mean renal artery occlusion time was 6.55 +/- 2.46 min (range, 2.29-13.21) with the PercuSurge device. Mean time in situ (filters) was 4.25 +/- 1.12 min. Mean follow-up was 22.6 +/- 17.6 months (range, 1-47). Systolic and diastolic blood pressure declined from 169.0 +/- 15.2 and 104.0 +/- 13.0 mm Hg, respectively, to 149.7 +/- 12.4 and 92.7 +/- 6.7 mm Hg after the procedure. The mean creatinine level remains constant during the follow-up. At 6-month follow-up (45 patients), renal function did not deteriorate in any patient, whereas 8 patients with baseline renal insufficiency improved after the procedure. At 3 years (19 patients), renal function deteriorated only in 1 patient with renal insufficiency and in 1 patient treated for bilateral renal stenosis, one side without protection. These preliminary results suggest the feasibility and safety of distal protection during renal interventions to protect against atheroembolism and to avoid renal function deterioration. This technique's beneficial effects should be evaluated by randomized studies. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 14571477     DOI: 10.1002/ccd.10669

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  12 in total

1.  Clinical outcomes in patients with renal artery stenosis treated with stent placement with embolic protection compared with those treated with stent alone.

Authors:  Ankaj Khosla; Sanjay Misra; Eddie L Greene; Axel Pflueger; Steve C Textor; Haraldur Bjarnason; Michael A McKusick
Journal:  Vasc Endovascular Surg       Date:  2012-06-11       Impact factor: 1.089

2.  Embolic protection device use in renal artery stent placement.

Authors:  Mallik R Thatipelli; Sanjay Misra; Srinivas R Sanikommu; Robert M Schainfeld; Sandeep K Sharma; Peter A Soukas
Journal:  J Vasc Interv Radiol       Date:  2009-03-27       Impact factor: 3.464

3.  Response of blood pressure after percutaneous transluminal renal artery angioplasty and stenting.

Authors:  Jayesh S Prajapati; Sharad R Jain; Hasit Joshi; Shaurin Shah; Kamal Sharma; Sibasis Sahoo; Kapil Virparia; Ashok Thakkar
Journal:  World J Cardiol       Date:  2013-07-26

Review 4.  Update on intervention versus medical therapy for atherosclerotic renal artery stenosis.

Authors:  Albeir Y Mousa; Ali F AbuRahma; Joseph Bozzay; Mike Broce; Mark Bates
Journal:  J Vasc Surg       Date:  2015-06       Impact factor: 4.268

Review 5.  Atherosclerotic renal artery stenosis--diagnosis and treatment.

Authors:  David Lao; Punit S Parasher; Kerry C Cho; Yerem Yeghiazarians
Journal:  Mayo Clin Proc       Date:  2011-07       Impact factor: 7.616

6.  Experience of stenting for atherosclerotic renal artery stenosis in a cardiac catheterization laboratory: technical considerations and complications.

Authors:  Percy P Jokhi; Krishnan Ramanathan; Simon Walsh; Anthony Y Fung; Jacqueline Saw; Rebecca S Fox; Nadia Zalunardo; Christopher E Buller
Journal:  Can J Cardiol       Date:  2009-08       Impact factor: 5.223

Review 7.  Clinical insights into the diagnosis and management of atherosclerotic renal artery disease.

Authors:  Michael J Bloch; Jan Basile
Journal:  Curr Atheroscler Rep       Date:  2006-09       Impact factor: 5.113

8.  Expanding use of embolic protection devices.

Authors:  Martin G Radvany; Michael Wholey
Journal:  Semin Intervent Radiol       Date:  2008-03       Impact factor: 1.513

Review 9.  Diagnosis and management of atherosclerotic renal artery stenosis: improving patient selection and outcomes.

Authors:  Christopher J White; Jeffrey W Olin
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

Review 10.  [Hypertension in patients with renal artery stenosis].

Authors:  A Voiculescu; L C Rump
Journal:  Internist (Berl)       Date:  2009-01       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.